Oncolytics Biotech (ONCY) Net Equity Issued and Repurchased (2009 - 2026)
Oncolytics Biotech (ONCY) posted Net Equity Issued and Repurchased of $7.15 million for Q2 2026, up 292.3% from $1.82 million a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Oncolytics Biotech was $9.25 million, up 331.2% year-over-year; for FY2025, it came in at $32,000, down 31.9% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -29.2% (FY2020 to FY2025).
- In prior years, Oncolytics Biotech's Net Equity Issued and Repurchased was $47,000 in FY2024 (-91.9%), $578,851 in FY2023, $9,230 in FY2022 (-95.1%) and $189,913 in FY2021 (+5.6%).
- The Q2 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since Q1 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.85 Bn | 1,097.43 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 634.21 Bn | 554.07 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 505.78 Bn | 478.89 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 357.64 Bn | 312.02 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 290.31 Bn | 254.30 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 265.38 Bn | 239.06 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 238.11 Bn | 193.51 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn | - |
| 10 | Oncolytics Biotech | 59.20 Mn | 30.32 Mn | - | 7.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.15 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Dec 31, 2023 | 275,450.82 |
| Sep 30, 2023 | 46,993.62 |
| Mar 31, 2022 | 9,473.70 |
| Dec 31, 2021 | 212,653.74 |
| Sep 30, 2021 | 3.84 Mn |
| Jun 30, 2021 | 5.50 Mn |
| Mar 31, 2021 | 149,605.27 |
| Dec 31, 2020 | 106,016.16 |
| Jun 30, 2020 | 12,720.60 |
| Mar 31, 2020 | 63,512.92 |
| Sep 30, 2019 | 4.51 Mn |
| Mar 31, 2019 | 3.53 Mn |
| Sep 30, 2018 | 87,777.00 |
| Jun 30, 2018 | 23,910.00 |
| Sep 30, 2017 | 48,090.00 |
| Jun 30, 2017 | 295,350.00 |
| Dec 31, 2015 | 1.93 Mn |
| Jun 30, 2015 | 2.38 Mn |
API Access
Oncolytics Biotech Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();